Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | RORC | P51449 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | RORB | Q92753 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27918802 | 0.84 | CES1 (0.37) | CES2CES1ALDH1A1LMNATSHR | |
| SCHEMBL27849711 | 0.83 | TSHR (0.48) | CES2CES1ALDH1A1RORCTSHR | |
| SCHEMBL18484279 | 0.76 | POLB (0.41) | CES2CES1ALDH1A1POLBRORC | |
| SCHEMBL15520760 | 0.76 | ALDH1A1 (0.43) | ALDH1A1POLBLMNATSHRHPGD | |
| SCHEMBL21248267 | 0.76 | CES2 (0.48) | CES2CES1ALDH1A1LMNAHPGD | |
| SCHEMBL12571853 | 0.74 | MAOA (0.43) | ALDH1A1TSHRHPGDHTTERCC5 | |
| SCHEMBL1471234 | 0.74 | CES1 (0.58) | CES2CES1ALDH1A1POLBRORC | |
| SCHEMBL27809181 | 0.74 | LMNA (0.50) | ALDH1A1POLBLMNATDP1 | |
| SCHEMBL29477191 | 0.74 | CES1 (0.58) | CES2CES1ALDH1A1POLBRORC | |
| SCHEMBL9493916 | 0.74 | CES2 (0.56) | CES2CES1ALDH1A1POLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190144469-A1 | METHOD FOR PREPARING DIFLUOROALLYLBORONATE AND APPLICATION THEREOF | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2019-05-16 | — | — | US | disclosed |
| CN-101400662-B | Substituted isoxazoline compound and pest control agent | NISSAN CHEMICAL IND LTD | 2012-11-14 | — | — | CN | disclosed |
| CN-102558082-A | Preparation intermediate compound of isoxazoline-substituted benzamide compound and noxious organism control agent | NISSAN CHEMICAL IND LTD | 2012-07-11 | — | — | CN | disclosed |
| CN-102532048-A | Isoxazoline-substituted benzamide compound and pesticide | NISSAN CHEMICAL IND LTD | 2012-07-04 | — | — | CN | disclosed |
| CN-102149696-A | Nitrogen-containing heterocyclic compound and pest control agent | NIPPON SODA CO | 2011-08-10 | — | — | CN | disclosed |
| CN-101801940-A | Substituted isoxazoline compound and pest control agent | NISSAN CHEMICAL IND LTD | 2010-08-11 | — | — | CN | disclosed |
| CN-101778833-A | Nitrogen-containing heterocyclic compound and pest control agent | NIPPON SODA CO | 2010-07-14 | — | — | CN | disclosed |
| CN-101768129-A | Production intermediate of isoxazoline-substituted benzamide compound | NISSAN CHEMICAL IND LTD | 2010-07-07 | — | — | CN | disclosed |
| CN-101400662-A | Substituted isoxazoline compound and pest control agent | NISSAN CHEMICAL IND LTD (JP) | 2009-04-01 | — | — | CN | disclosed |
| CN-1930136-A | isoxazoline-substituted benzamide compound and pest control agent | NISSAN CHEMICAL IND LTD | 2007-03-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190144469-A1 | METHOD FOR PREPARING DIFLUOROALLYLBORONATE AND APPLICATION THEREOF | GABRA6, GABRP, GABBR2 | CES2 2928/4885CES1 3239/4885ALDH1A1 1498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.